These observations support our findings of a role for AQP4 gene polymorphisms in both MS risk and rehabilitation outcomes, which could be mediated by the modulation of AQP4 expression and polarization, resulting in more efficient glymphatic clearance and astrocyte-mediated neurorepair mechanisms. This evidence concerns the gene AQP4 and myeloid sarcoma.